Contribution of limbic norepinephrine to cannabinoid-induced aversion.
about
Cannabinoid abuse and addiction: Clinical and preclinical findingsCannabinoid and opioid interactions: implications for opiate dependence and withdrawalCannabinoid modulation of noradrenergic circuits: implications for psychiatric disordersHindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functionsInteractions between brainstem noradrenergic neurons and the nucleus accumbens shell in modulating memory for emotionally arousing eventsNoradrenergic alpha-2 receptor modulators in the ventral bed nucleus of the stria terminalis: effects on anxiety behavior in postpartum and virgin female rats.Endocannabinoid signaling in the etiology and treatment of major depressive illness.Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat.Chronic alcohol exposure differentially affects activation of female locus coeruleus neurons and the subcellular distribution of corticotropin releasing factor receptors.Repeated administration of a synthetic cannabinoid receptor agonist differentially affects cortical and accumbal neuronal morphology in adolescent and adult ratsEffects of noradrenergic alpha-2 receptor antagonism or noradrenergic lesions in the ventral bed nucleus of the stria terminalis and medial preoptic area on maternal care in female ratsModulating the modulators: interaction of brain norepinephrine and cannabinoids in stress.Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure.Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion.
P2860
Q26851944-FAA2F39A-0483-4F06-BF11-4EB618CCA995Q27000762-D0E51C23-FB1A-47A5-B2F9-2A183DBFB9B9Q27001139-EE1E14B8-D55C-4098-8D65-951BC597384AQ28296208-72474E7E-5116-46D7-B151-407A05B73950Q30426709-EBE7BABA-6290-4907-B8E7-F8CA3BC19E9EQ30433556-66B51384-7C9F-4995-BF94-16BAC83B5423Q30687668-8AB0E964-0D0E-4AE0-A0DF-8561ECBD53AAQ34367943-2C6BD964-B4FD-4FCA-A787-5E4150561981Q34647295-2AF74583-3428-449A-95DE-C3EC89911AA9Q35547422-C3B71989-621D-497F-9C16-25AB66898E99Q36838912-70A0BE96-F5A3-4B58-B7E7-2011185CF784Q37332115-0294092A-7D77-4B40-825B-1BBC24C20FF4Q37529127-453B9CFA-7E03-47DE-8584-07791225C21EQ38877585-076CC85E-6FE1-45A3-887C-7FDDC0ED836CQ39658389-E5F39483-5799-4838-AA68-5E7B4E6D014A
P2860
Contribution of limbic norepinephrine to cannabinoid-induced aversion.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Contribution of limbic norepinephrine to cannabinoid-induced aversion.
@en
type
label
Contribution of limbic norepinephrine to cannabinoid-induced aversion.
@en
prefLabel
Contribution of limbic norepinephrine to cannabinoid-induced aversion.
@en
P2093
P2860
P1433
P1476
Contribution of limbic norepinephrine to cannabinoid-induced aversion
@en
P2093
Arith-Ruth S Reyes
Elisabeth J Van Bockstaele
Ellen Unterwald
Robert C Sterling
P2860
P2888
P304
P356
10.1007/S00213-010-1923-7
P577
2010-07-03T00:00:00Z
P5875
P6179
1023298476